Trimestaâ„¢ (oral estriol) MS trial receives research grant
Posted: Tue May 03, 2011 7:24 am
Adeona Pharmaceuticals, Inc. announced today that after scientific review, the ongoing clinical trial of its Trimesta™ (oral estriol) drug candidate for multiple sclerosis (MS) has received an additional $1,594,553 in grant funding from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS).
The clinical trial is led by Rhonda Voskuhl, M.D., Director, University of California, Los Angeles (UCLA) Multiple Sclerosis Program, UCLA Department of Neurology. Along with the recent grant award of $409,426 received from the National Multiple Sclerosis Society (NMSS), this NIH/NINDS grant award should support the ongoing Trimesta clinical trial to its completion....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1878